A new research report titled; ‘Global Single use Bioprocessing Market’ has been added into the vast repository of research reports by MarketsandMarkets™ INC. The research report covers a detailed analysis of the overview of the market, overall size, share, product definition, supply chain analysis, supply chain ratio, upstream raw materials and equipment, downstream demand analysis, and import/export details. The report further analyses the different approaches, procedures, strategies, and methodologies adopted by the leading competitors operating in the market to make strategic key business decisions. Apart from the above-mentioned key findings, the report also states the growth rate of the global market, as well as the facts, figures, consumption tables, and statistics of the leading segments.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297
Additionally, the Global Single use Bioprocessing Market research report provides an in-depth study of the current scenario of the market, along with the current and future industry trends, in order to identify the investment analysis.
Single-use bioprocessing is a rapidly evolving technology used to develop disposable bioprocessing equipment and accessories to manufacturing biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, and stem cells. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind using single-use bioprocessing technology in the bioprocess is to decrease the cost associated with complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.
Single use Bioprocessing Overview:
The global single use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5%
Furthermore, the Global Single use Bioprocessing Market Research Report provides the competitive landscape of the market and gathers information with regards to the company overview, contact information, market size and share, company’s headquarters and corporate offices, and sales revenue.
The report also discusses the different development plans and policies of the industry, product pictures, and the process of manufacturing the product, production volume, and product draft.
Moreover, the report provides an in-depth survey of the industry feasibleness, market strategies, investment return analysis, product volume, supply and demand ratio, market utilization value, and the industry chain value. In the last section of the report, the key distributors, suppliers, distinct traders, as well as the sales and distribution challenge, research findings, data resources, and appendix, have been studied.
Single use Bioprocessing Industry | Key Market Players:
Sartorius Stedim Biotech S.A. (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), Corning (US), Entegris (US), Avantor (US), CESCO Bioengineering Co. Ltd. (Taiwan), Cellexus (UK), PBS Biotech, Inc. , Distek, Inc. (US), ABEC, Inc. (US), Able Corporation & Biott Corporation (Japan), G&G Technologies (US), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech (Netherlands), Meissner Filtration Products, Inc. (US), bbi-biotech GmbH (Germany), Pierre Guerin (France), Kuhner AG (Switzerland), OmniBRx Biotechnologies (India).
Media bags and Containers segment accounted for the largest share of the product segment
Based on product, the single-use bioprocessing market is categorized into single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and other products. The other products segment includes single-use vessels, tubing, connectors. In 2020, the single-use media bags and containers segment accounted for the largest share of 30.7% of the global single-use bioprocessing market by product. Single-use bioprocessing systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharmaceutical applications.
The filtration segment accounted for the largest share of the application segment
Based on the application, the single-use bioprocessing market is categorized into five segments based on applications: filtration, mixing, purification, storage, and cell culture. Over the years, technological advancements and the growing adoption of single-use technologies have played a crucial role in widening the applications of single-use bioprocessing systems. Single-use bioprocessing systems are mainly used in upstream and downstream processes in life sciences R&D and biopharmaceutical manufacturing processes.
The filtration segment accounted for the largest share
The global single-use bioprocessing market is categorized into five segments based on applications: filtration, mixing, purification, storage, and cell culture. In 2020, the filtration segment accounted for the largest share of the global single-use bioprocessing market followed by storage application.
Global Single use Bioprocessing Market Dynamics:
- DRIVER: The growing demand for biopharmaceuticals
- RESTRAINT: Issues related to leachables and extractables
- OPPORTUNITY: Emerging markets
- CHALLENGE: Waste disposal
Segments and Subsegments:
- Single-use media bags and containers | assemblies | bioreactors
- Disposable mixers
- Other products
- Cell culture
- Biopharmaceutical & Pharmaceutical companies
- Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
- Academic & Research institutes
Some of the key geographies mentioned in this report include:
- North America (U.S and Canada and rest of North America)
- Europe (Germany, France, Italy, and Rest of Europe)
- Asia Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)
- LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)
- In March 2020, Danaher acquired the Biopharma business from General Electric Company’s Life Sciences division. The business is called Cytiva, and is a standalone operating company within Danaher’s Life Sciences segment.
- In September 2020, Thermo Fisher Scientific invested more than USD 475 million in new capabilities at its St. Louis site to expand biologics development and manufacturing, cell and gene therapy capabilities, and drug product development capabilities.
Mr. Aashish Mehra
630 Dundee Road, Suite 430, Northbrook, IL 60062
USA: 1-888-600-6441 | firstname.lastname@example.org
Home Healthcare Market: https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-696.html
Optometry Equipment Market: https://www.marketsandmarkets.com/Market-Reports/optometry-eye-exam-equipment-market-14475790.html
Epigenetics Market: https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html
Medical Electrodes Market: https://www.marketsandmarkets.com/Market-Reports/medical-electrode-market-171260948.html
Point of Care Molecular Diagnostics Market: https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html
Enteral Feeding Devices Market: https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-device-market-183623035.html